Literature DB >> 33375700

Cholesterol Metabolites 25-Hydroxycholesterol and 25-Hydroxycholesterol 3-Sulfate Are Potent Paired Regulators: From Discovery to Clinical Usage.

Yaping Wang1, Xiaobo Li2, Shunlin Ren1.   

Abstract

Oxysterols have long been believed to be ligands of nuclear receptors such as liver × receptor (LXR), and they play an important role in lipid homeostasis and in the immune system, where they are involved in both transcriptional and posttranscriptional mechanisms. However, they are increasingly associated with a wide variety of other, sometimes surprising, cell functions. Oxysterols have also been implicated in several diseases such as metabolic syndrome. Oxysterols can be sulfated, and the sulfated oxysterols act in different directions: they decrease lipid biosynthesis, suppress inflammatory responses, and promote cell survival. Our recent reports have shown that oxysterol and oxysterol sulfates are paired epigenetic regulators, agonists, and antagonists of DNA methyltransferases, indicating that their function of global regulation is through epigenetic modification. In this review, we explore our latest research of 25-hydroxycholesterol and 25-hydroxycholesterol 3-sulfate in a novel regulatory mechanism and evaluate the current evidence for these roles.

Entities:  

Keywords:  25-hydroxycholesterol 3,25-disulfate; 25-hydroxycholesterol 3-sulfate; 25-hydroxysterol; epigenetic regulators; oxysterol sulfates; oxysterol sulfation

Year:  2020        PMID: 33375700      PMCID: PMC7823450          DOI: 10.3390/metabo11010009

Source DB:  PubMed          Journal:  Metabolites        ISSN: 2218-1989


  85 in total

1.  An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha.

Authors:  B A Janowski; P J Willy; T R Devi; J R Falck; D J Mangelsdorf
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

2.  Regulation of hepatocyte lipid metabolism and inflammatory response by 25-hydroxycholesterol and 25-hydroxycholesterol-3-sulfate.

Authors:  Leyuan Xu; Qianming Bai; Daniel Rodriguez-Agudo; Phillip B Hylemon; Douglas M Heuman; William M Pandak; Shunlin Ren
Journal:  Lipids       Date:  2010-08-11       Impact factor: 1.880

3.  High levels of oxysterol sulfates in serum of patients with steroid sulfatase deficiency.

Authors:  Alberto Sánchez-Guijo; Vinzenz Oji; Michaela F Hartmann; Hans-Christian Schuppe; Heiko Traupe; Stefan A Wudy
Journal:  J Lipid Res       Date:  2014-12-11       Impact factor: 5.922

4.  Overexpression of cholesterol transporter StAR increases in vivo rates of bile acid synthesis in the rat and mouse.

Authors:  Shunlin Ren; Phillip B Hylemon; Dalila Marques; Emily Gurley; Patricia Bodhan; Elizabeth Hall; Kaye Redford; Gregorio Gil; William M Pandak
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

Review 5.  A paradigm for gene regulation: inflammation, NF-kappaB and PPAR.

Authors:  Wim Vanden Berghe; Linda Vermeulen; Philippe Delerive; Karolien De Bosscher; Bart Staels; Guy Haegeman
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

6.  24-hydroxycholesterol sulfation by human cytosolic sulfotransferases: formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity, and inhibition of liver x receptor activation.

Authors:  Ian T Cook; Zofia Duniec-Dmuchowski; Thomas A Kocarek; Melissa Runge-Morris; Charles N Falany
Journal:  Drug Metab Dispos       Date:  2009-07-09       Impact factor: 3.922

7.  Oxysterol Restraint of Cholesterol Synthesis Prevents AIM2 Inflammasome Activation.

Authors:  Eric V Dang; Jeffrey G McDonald; David W Russell; Jason G Cyster
Journal:  Cell       Date:  2017-10-12       Impact factor: 41.582

8.  Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD.

Authors:  Johannie du Plessis; Hannelie Korf; Jos van Pelt; Petra Windmolders; Ingrid Vander Elst; An Verrijken; Guy Hubens; Luc Van Gaal; David Cassiman; Frederik Nevens; Sven Francque; Schalk van der Merwe
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

Review 9.  An update on oxysterol biochemistry: New discoveries in lipidomics.

Authors:  William J Griffiths; Yuqin Wang
Journal:  Biochem Biophys Res Commun       Date:  2018-02-05       Impact factor: 3.575

Review 10.  The Roles of Cholesterol and Its Metabolites in Normal and Malignant Hematopoiesis.

Authors:  Hideyuki Oguro
Journal:  Front Endocrinol (Lausanne)       Date:  2019-04-02       Impact factor: 5.555

View more
  4 in total

Review 1.  Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).

Authors:  Xiaohan Xu; Kyle L Poulsen; Lijuan Wu; Shan Liu; Tatsunori Miyata; Qiaoling Song; Qingda Wei; Chenyang Zhao; Chunhua Lin; Jinbo Yang
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

2.  Oxysterols and Oxysterol Sulfates in Alzheimer's Disease Brain and Cerebrospinal Fluid.

Authors:  Irundika H K Dias; Hala Shokr; Freya Shephard; Lisa Chakrabarti
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

3.  25-Hydroxycholesterol 3-Sulfate Recovers Acetaminophen Induced Acute Liver Injury via Stabilizing Mitochondria in Mouse Models.

Authors:  Yaping Wang; William M Pandak; Edward J Lesnefsky; Phillip B Hylemon; Shunlin Ren
Journal:  Cells       Date:  2021-11-05       Impact factor: 6.600

4.  27-Hydroxycholesterol, The Estrogen Receptor Modulator, Alters DNA Methylation in Breast Cancer.

Authors:  Ravindran Vini; Arumugam Rajavelu; Sreeja Sreeharshan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-10       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.